Division of Hematologic Malignancies
Leadership
- Interim Director, Division of Hematologic Malignancies
- Director Clinical Research, Sydney Kimmel Comprehensive Cancer Center
- Director, Leukemia Program
- Professor of Medical Oncology
1101 Chestnut Street
14th Floor
Philadelphia, PA 19107
For Patient Inquiries
New Patients: 1-800-JEFF-NOW
Existing Patients: 215-955-8874
Transplant & Cell Therapy Group
The Transplant & Cell Therapy (TCT) team at Jefferson delivers the skilled and comprehensive care you need. Jefferson is advancing the state of the art in this field, and is capable of successfully performing transplants that are not undertaken by most transplant centers around the country.
Hematologic Cancers Group
Designated a center of excellence in cancer care and research, Thomas Jefferson University Hospitals' Kimmel Cancer Center treats patients with hematological malignancies, the most common forms of which are leukemia (acute and chronic myelogenous and lymphocytic), Hodgkins and non-Hodgkins lymphoma and multiple myeloma.